MBX
MBX Biosciences Inc.
$31.75
-$0.10(-0.31%)
45
Overall
60
Value
41
Tech
34
Quality
Market Cap
$34.31M
Volume
247.58K
52W Range
$9.43 - $45.85
Target Price
$69.09
Company Overview
| Mkt Cap | $34.31M | Price | $31.75 |
| Volume | 247.58K | Change | -0.31% |
| P/E Ratio | -0.4 | Open | $32.22 |
| Revenue | -- | Prev Close | $31.85 |
| Net Income | $-87.0M | 52W Range | $9.43 - $45.85 |
| Div Yield | N/A | Target | $69.09 |
| Overall | 45 | Value | 60 |
| Quality | 34 | Technical | 41 |
No chart data available
Latest News
LifeSci Capital Remains a Buy on MBX Biosciences, Inc. (MBX)
TipRanks Auto-Generated Intelligence Newsdesk•10 days ago
Mizuho Securities Reaffirms Their Buy Rating on MBX Biosciences, Inc. (MBX)
TipRanks Auto-Generated Intelligence Newsdesk•19 days ago
Analysts Offer Insights on Healthcare Companies: Armata Pharmaceuticals (ARMP), Palvella Therapeutics (PVLA) and MBX Biosciences, Inc. (MBX)
Christine Brown•19 days ago
Guggenheim Keeps Their Buy Rating on MBX Biosciences, Inc. (MBX)
TipRanks Auto-Generated Intelligence Newsdesk•22 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MBX | $31.75 | -0.3% | 247.58K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |